Sarepta Therapeutics, Inc.

institutional

Managed by Sarepta Therapeutics, Inc. • Latest filing Q4 2025

Portfolio value

Q4 2025

Filings

Quarterly 13F history

Top-10 concentration

—

Weight of largest holdings

Annualized return

—

Implied from 13F holdings

Top holdings

#	Stock	Value	Shares	% Portfolio	Change
1	C CVX —	$0	0	0.00%	—

—

Value

% Port

0.00%

Overlap peers will appear here as data populates

Related fund suggestions coming soon.